Momenta Pharmaceuticals, Inc.has announced that Shire has exercised its right to terminate its collaboration agreement with the Company to develop...
The FORTIS-M trial of talactoferrin from Aggenix AG, investigated the effect of talactoferrin plus best supportive care (BSC) compared with...
The FDA has requested data from AstraZeneca as part of its investigation a possible association between use of Onglyza for...
Lumicell, Inc., announced the FDA approved the company’s New Drug Application (NDA) for its Lumisight (pegulicianine) optical imaging agent and its Premarket Approval (PMA) application for Lumicell Direct Visualization System (DVS), together referred to as LumiSystem
NxThera announced that new data from the first post-market clinical evaluation of its minimally invasive Rezu?m Radiofrequency System demonstrated significant,...
BiondVax Pharmaceuticals announced topline data from the Company's pivotal, phase III clinical trial of M 001 as a standalone universal flu vaccine candidate.
Roche announced that its new hematology testing solution, the cobas m 511 integrated hematology analyzer, has received 510(k) clearance from...
Signifor (pasireotide)from Novartis, significantly reduced urinary cortisol levels and improved symptoms of Cushing's disease in the largest clinical study of...